Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

We create an individualized treatment plan for you, drawing upon our expertise in endoscopic and surgical treatments as well as medical therapies.

Meet Our Doctors

Our Approach to Treating Pancreatic Cancer

Our Approach to Pancreatic Cancer Treatment

Diagnosis

Surgery

Chemotherapy & Targeted Drugs

Radiation Therapy

Clinical Trials and Research Studies

Phase 1

Phase 1b Open-label Study of MK-7162 in Combination with Pembrolizumab (MK-3475) +/- other therapies in Participants with Advanced Solid Tumors

Learn More

Phase 3

A Phase III Randomised Double Blind Placebo Controlled Multicentre Study of Maintenance Olaparib Monotherapy in Patients with gBRCA Mutated Metastatic Pancreatic Cancer whose Disease Has Not Progressed on First Line Platinum Based Chemotherapy

Learn More

Phase 1/2

A Phase I/IIa Study of BMS-986205 Administered in Combination with Nivolumab (BMS-935558 anti-PD-1 Monoclonal Antibody) in Advanced Malignant Tumors

Learn More

Phase 2

Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Learn More

View All Related Clinical Trials (5)